Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
2.695
+0.085 (3.26%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $456.01 million as of April 17, 2025. Its market cap has decreased by -51.31% in one year.
Market Cap
456.01M
Enterprise Value
-276.81M
1-Year Change
-51.31%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $456.01M, a decrease of -84.97%. That is a compound annual growth rate of -32.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 456.01M | -33.87% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.93B |
| UnitedHealth Group | 535.14B |
| Johnson & Johnson | 370.90B |
| AbbVie | 303.70B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 224.94B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |